Saline control
Phase 1
Saline control is one of 2 therapeutic programs targeting Tympanic Membrane Perforation. It is currently in Phase 1.
2
Indications
2
Total Trials
2
Active Trials
1
Competitors
Pipeline
Status by Indication[2][1]
Competition
Competitive Landscape
1 competitor in Venous Distension Reflex
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Saline control. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 1[1]
- Company
- DD. Bradley Welling, MD, PhD